Martin Hudec | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Martin Hudec | Medicine | Best Researcher Award

Dr. Martin Hudec, Middle-Slovak Institute of Cardiovascular Diseases (SUSCCH), Slovakia

Dr. Martin Hudec is a distinguished Interventional Cardiologist with extensive experience in cardiovascular diseases. He serves as the Head of the Department of Acute Cardiology at the Middle Slovak Institute of Cardiovascular Diseases, Slovakia. Holding multiple prestigious qualifications, including MUDr., PhD., MBA, MRCPI, and FESC, he specializes in percutaneous myocardial revascularization and advanced cardiac interventions. His research focuses on improving treatment outcomes for chronic heart failure patients. Over the years, Dr. Hudec has contributed significantly to Slovak and European cardiology through leadership roles, including as a board member of the Slovak Society of Cardiology. An active researcher and educator, he serves as an External Cardiology Tutor at the Slovak Medical University. Recognized internationally, he is a Fellow of the European Society of Cardiology (FESC) and a Member of the Editorial Board of SEEJCA. His commitment to excellence in interventional cardiology continues to shape the field.

Professional Profile

Scopus

Orcid

Research for Best Researcher Award – Martin Hudec

Dr. Martin Hudec is highly deserving of the Research for Best Researcher Award due to his extensive academic background, notable clinical experience, and impactful contributions to the field of cardiology. As a highly qualified specialist in Interventional Cardiology, Dr. Hudec has demonstrated an exceptional commitment to both patient care and research. His qualifications include a Doctor of Medicine (MUDr.), PhD, MBA, and various prestigious certifications, including the MRCPI (Royal College of Physicians of Ireland) and FESC (Fellow of the European Society of Cardiology). His research has significantly advanced the understanding of myocardial revascularization, especially its impact on chronic heart failure, as demonstrated in his PhD dissertation at Comenius University.

Throughout his career, Dr. Hudec has held influential roles in numerous cardiology societies, including serving as a board member for the Slovak Society of Cardiology and the Slovak Resuscitation Society. His contributions to education and knowledge dissemination are equally remarkable, as he serves as an external cardiology tutor at the Slovak Medical University and is a member of the editorial board for the South East European Journal of Cardiology. These roles underscore his leadership in shaping the next generation of cardiologists and his commitment to advancing the field.

🎓 Education

Dr. Martin Hudec’s medical journey began at the Jessenius Faculty of Medicine, Comenius University, Slovakia, where he graduated with distinction in 2004. He completed his General Professional Training (GPT) in 2006 and earned Membership of the Royal College of Physicians of Ireland (MRCPI) in 2008. Pursuing excellence, he completed his Specialty Certificate in Cardiology (CCT) in 2011 and later defended his PhD dissertation on percutaneous myocardial revascularization and chronic heart failure in 2018. His academic contributions are further recognized through leadership roles, including Board Member of the Slovak Society of Cardiology and Head of the Interventional Cardiology Committee. As an educator, he plays a vital role as a Cardiology Tutor at Slovak Medical University. His academic journey reflects a deep commitment to advancing cardiovascular medicine through education, research, and clinical expertise, shaping the next generation of cardiologists.

💼 Professional Experience 

Dr. Martin Hudec has a stellar career in interventional cardiology, marked by leadership and clinical excellence. Since 2014, he has served as the Head of the Department of Acute Cardiology at the Middle Slovak Institute of Cardiovascular Diseases. He previously held the role of Head of the Coronary Care Unit (2012-2014) and worked as a Consultant Interventional Cardiologist (2011-present). His expertise was further honed during a Fellowship in Interventional Cardiology at Cork University Hospitals, Ireland (2007-2009), before returning to Slovakia as a Specialist Registrar (2009-2011). Dr. Hudec is an External Cardiology Tutor at Slovak Medical University, actively contributing to medical education. His leadership extends to serving on the board of Slovak and European cardiology committees, ensuring the advancement of interventional techniques and patient care. His dedication has positioned him as a key figure in Slovak cardiovascular medicine.

🏅 Awards and Recognition 

Dr. Martin Hudec is a Fellow of the European Society of Cardiology (FESC), a prestigious recognition of his contributions to cardiovascular medicine. He is a Board Member of the Slovak Society of Cardiology and Head of the Interventional Cardiology Committee, reflecting his leadership in the field. His research excellence was acknowledged with a PhD award for his dissertation on myocardial revascularization in 2018. In 2021, he was appointed as a Member of the Editorial Board of the South East European Journal of Cardiology (SEEJCA). Additionally, he played a pivotal role in Slovak Resuscitation Society and ESC eLearning Platform. His consistent efforts in cardiology research and patient care have earned him widespread respect among peers and international recognition. As an advocate for innovation in cardiovascular treatment, Dr. Hudec continues to shape the future of interventional cardiology through education, research, and practice.

🌍 Research Skills On Medicine

Dr. Martin Hudec specializes in interventional cardiology, focusing on percutaneous myocardial revascularization and chronic heart failure treatment. His research integrates advanced cardiovascular imaging, catheter-based interventions, and hemodynamic analysis to improve patient outcomes. He has contributed to evidence-based clinical guidelines, enhancing treatment strategies for acute coronary syndrome and structural heart diseases. His expertise in endovascular techniques and stent technologies has positioned him at the forefront of modern cardiology. As a board member of cardiology committees, he actively participates in international research collaborations. His research extends to resuscitation science, electrophysiology, and cardiovascular risk assessment, aiming to reduce mortality rates in cardiac patients. Dr. Hudec’s work is frequently published in peer-reviewed medical journals, and he plays a crucial role in mentoring young cardiologists. His ability to merge clinical practice with innovative research has made him a leading authority in interventional cardiology.

đź“– Publication Top Notes

  • Title: Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis
    Authors: Niels van Royen, Ignacio J. Amat, Martin Hudec, Patrick W. Serruys, Andreas Baumbach, et al.
    Journal: EuroIntervention
    Year: 2025
    Citations: 2

  • Title: LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial
    Authors: Andreas Baumbach, Niels van Royen, Ignacio J. Amat, Ferencz Arnold-Béla, Orsolya Demeterné Kiss, et al.
    Journal: The Lancet
    Year: 2024
    Citations: 16

  • Title: Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX Slovakia Registry
    Authors: Martin Hudec, Andrej Kupec, Pavol Gazdic, et al.
    Journal: Anatolian Journal of Cardiology
    Year: 2024

 

Do Young Kim | Medicine | Best Researcher Award

Posted on by sciencefather

Prof. Do Young Kim | Medicine | Best Researcher Award

Prof. Do Young Kim, Yonsei University College of Medicine South Korea

Do Young Kim is a Professor of Internal Medicine at Yonsei University College of Medicine and a hepatologist at Severance Hospital in Seoul, Korea. Having been part of the faculty since 2007, Dr. Kim is widely recognized for his contributions to hepatology, particularly in hepatocellular carcinoma (HCC). He earned his medical degree from Yonsei University in 1996 and completed his training at Severance Hospital. Dr. Kim’s research experience includes a position as a research associate at Fred Hutchinson Cancer Research Center from 2011 to 2012, where he focused on proteomics and microRNA in HCC.

Professional Profile 

Scopus 

Orcid

Google Scholar

Summary of Suitability for the “Research for Best Researcher Award”

Professor Do Young Kim, a prominent figure in hepatology and internal medicine, has made significant contributions to the field of hepatocellular carcinoma (HCC) and hepatitis C research. As a professor at Yonsei University College of Medicine and a hepatologist at Severance Hospital, he has established himself as a leading expert in his field since 2007. His academic background, including his degree from Yonsei University and specialized training at Severance Hospital, laid a solid foundation for his remarkable career.

His research focus on proteomics and microRNA in HCC, particularly during his tenure at the Fred Hutchinson Cancer Research Center, has led to innovative insights into the mechanisms underlying liver cancer and hepatitis C. This focus has translated into a series of impactful publications, where he has served as the corresponding author in studies that explore new treatment paradigms and diagnostic advancements for HCC. His work on the efficacy and safety of various treatments, including sorafenib and lenvatinib, has become essential reading for clinicians and researchers alike.

🎓 Education 

Dr. Do Young Kim obtained his medical degree from Yonsei University in Seoul, Korea, in 1996. After completing his studies, he underwent medical training at Severance Hospital, where he continued his professional development until 2001. In 2011, Dr. Kim broadened his academic horizons by becoming a research associate at Fred Hutchinson Cancer Research Center, where he focused on proteomics and microRNA in hepatocellular carcinoma (HCC). This international research experience allowed him to deepen his expertise in the molecular aspects of liver cancer. Dr. Kim’s ongoing contributions to medical education and his research have been deeply influenced by his foundational education and global training experiences.

💼 Professional Experience 

Dr. Do Young Kim is currently serving as a Professor of Internal Medicine at Yonsei University College of Medicine and a hepatologist at Severance Hospital in Seoul, Korea. Since joining Severance Hospital in 2007, he has become an integral part of the team, specializing in hepatology and liver diseases. His research has advanced understanding in areas such as hepatocellular carcinoma (HCC) and hepatitis C. In 2011-2012, Dr. Kim expanded his professional expertise by working as a research associate at the Fred Hutchinson Cancer Research Center in Seattle, USA. There, he conducted cutting-edge research in proteomics and microRNA in relation to HCC, which added a new dimension to his medical and scientific career. His ongoing clinical and research contributions have made him a leader in the field of hepatology.

🏅 Awards and Recognition

Dr. Do Young Kim has received significant recognition in the field of hepatology, with several prestigious awards throughout his career. His research on hepatocellular carcinoma (HCC) and hepatitis C has earned him acknowledgment both nationally and internationally. He is particularly recognized for his contributions to clinical practices surrounding HCC and his extensive publication record in highly respected medical journals. His role as a corresponding author in key studies, such as those published in Hepatology and J Gastroenterol Hepatol, highlights his leadership in advancing knowledge about liver disease. Dr. Kim’s research and clinical expertise have earned him the trust and respect of colleagues in the medical community, solidifying his position as a leading expert in the field of internal medicine and hepatology.

🌍 Research Skills On Medicine

Dr. Do Young Kim’s research skills are highly regarded, particularly in the fields of hepatocellular carcinoma (HCC) and hepatitis C. He specializes in proteomics and microRNA, utilizing these molecular techniques to gain deeper insights into the pathophysiology of liver diseases. His time at the Fred Hutchinson Cancer Research Center honed his skills in advanced research methodologies, which he continues to apply in his work at Severance Hospital and Yonsei University College of Medicine. Dr. Kim’s research is both experimental and clinical, bridging the gap between laboratory findings and real-world medical applications. He is skilled in conducting large-scale studies, analyzing complex data, and collaborating with multidisciplinary teams to advance scientific understanding. His research has led to significant clinical improvements in the management of liver diseases, particularly in HCC treatment and early detection.

đź“– Publication Top Notes

  • Letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”
    • Authors: Chon, Y.E., Kim, D.Y., Chon, H.J., Kim, D.Y.
    • Citation: Clinical and Molecular Hepatology, 2025, 31(1), pp. e98–e100
  • The Possible Impact of Zinc-Enriched Multivitamins on Treatment-NaĂŻve Recurrent Aphthous Stomatitis Patients
    • Authors: Seo, H.R., Chung, K.B., Kim, D.-Y.
    • Citation: Journal of Clinical Medicine, 2025, 14(1), 260
  • Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
    • Authors: Kim, J.E., Lee, S., Kang, H., Lee, Y.W., Kim, M.-B.
    • Citation: Annals of Dermatology, 2024, 36(6), pp. 376–383
  • Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
    • Authors: Kim, K.-P., Kim, K.M., Ryoo, B.-Y., Kim, J.-A., Kim, K.-H.
    • Citation: Liver Cancer, 2024, 13(6), pp. 610–628
  • Detection of NUDT15 R139C Variants and Azathioprine Utilization in Patients with Dermatologic Conditions
    • Authors: Chung, K.B., Sung, H., Kim, D.-Y.
    • Citation: International Journal of Dermatology, 2024, 63(3), pp. e75–e77
  • Quantitative Analysis of Hair Luster in a Novel Ultraviolet-Irradiated Mouse Model
    • Authors: Chung, K.B., Lee, Y.I., Kim, Y.J., Kim, D.-Y., Lee, J.H.
    • Citation: International Journal of Molecular Sciences, 2024, 25(3), 1885
    • Citations: 1
  • Heterogeneity in Keloid Scars: Influence of Mechanical Stretching on Keloids Arising from Different Anatomical Sites
    • Authors: Lee, Y.I., Yang, Y., Ham, S., Kim, D.-Y., Lee, J.H.
    • Citation: Journal of Investigative Dermatology, 2024
  • The Efficacy of Treatment for Hepatocellular Carcinoma in Elderly Patients
    • Authors: Lee, H.A., Lee, S., Lee, H.L., Rhim, H., Kim, D.Y.
    • Citation: Journal of Liver Cancer, 2023, 23(2), pp. 362–376
    • Citations: 2
  • Predictive Biomarkers of Survival in Patients with Advanced Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Treatment
    • Authors: Chon, Y.E., Cheon, J., Kim, H., Chon, H.J., Kim, B.K.
    • Citation: Cancer Medicine, 2023, 12(3), pp. 2731–2738
    • Citations: 26
  • Activated TAZ Induces Liver Cancer in Collaboration with EGFR/HER2 Signaling Pathways
    • Authors: Moon, H., Park, H., Chae, M.J., Kim, D.Y., Ro, S.W.
    • Citation: BMC Cancer, 2022, 22(1), 423
    • Citations: 11